{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:09:12Z","timestamp":1648634952656},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00120-020-01429-w","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T20:43:54Z","timestamp":1610743434000},"page":"186-192","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qualit\u00e4tskriterien in der Therapie des Peniskarzinoms"],"prefix":"10.1007","volume":"60","author":[{"given":"A.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"K\u00f6lling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Haferkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Tsaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg\u00a0OW, Comperat\u00a0EM, Minhas\u00a0S, Necchi\u00a0A, Protzel\u00a0C, Watkin\u00a0N (2015) EAU guidelines on penile cancer: 2014 update. Eur Urol 67:142\u2013150","journal-title":"Eur Urol"},{"key":"1429_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","volume":"5","author":"S Misra","year":"2004","unstructured":"Misra\u00a0S, Chaturvedi\u00a0A, Misra\u00a0NC (2004) Penile carcinoma: a\u00a0challenge for the developing world. Lancet Oncol 5:240\u2013247","journal-title":"Lancet Oncol"},{"key":"1429_CR3","first-page":"646","volume":"115","author":"OW Hakenberg","year":"2018","unstructured":"Hakenberg\u00a0OW, Drager\u00a0DL, Erbersdobler\u00a0A, Naumann\u00a0CM, Junemann\u00a0KP, Protzel\u00a0C (2018) The diagnosis and treatment of penile cancer. Dtsch Arztebl Int 115:646\u2013652","journal-title":"Dtsch Arztebl Int"},{"key":"1429_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2147\/CLEP.S99513","volume":"8","author":"JK Jakobsen","year":"2016","unstructured":"Jakobsen\u00a0JK, Ozturk\u00a0B, Sogaard\u00a0M (2016) The Danish national penile cancer quality database. Clin Epidemiol 8:589\u2013594","journal-title":"Clin Epidemiol"},{"key":"1429_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.euo.2018.10.006","volume":"2","author":"SB Williams","year":"2019","unstructured":"Williams\u00a0SB, Ray-Zack\u00a0MD, Hudgins\u00a0HK, Oldenburg\u00a0J, Trinh\u00a0QD, Nguyen\u00a0PL et al (2019) Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. Eur Urol Oncol 2:265\u2013273","journal-title":"Eur Urol Oncol"},{"key":"1429_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1308\/003588410X12518836439047","volume":"92","author":"AC Bayles","year":"2010","unstructured":"Bayles\u00a0AC, Sethia\u00a0KK (2010) The impact of improving outcomes guidance on the management and outcomes of patients with carcinoma of the penis. Ann R Coll Surg Engl 92:44\u201345","journal-title":"Ann R Coll Surg Engl"},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.euf.2017.02.009","volume":"4","author":"F Fenner","year":"2018","unstructured":"Fenner\u00a0F, Goody\u00a0D, Protzel\u00a0C, Erbersdobler\u00a0A, Richter\u00a0C, Hartz\u00a0JM et\u00a0al (2018) E2F1 signalling is predictive of chemoresistance and lymphogenic metastasis in penile cancer: a pilot functional study reveals new prognostic biomarkers. Eur Urol Focus 4:599\u2013607","journal-title":"Eur Urol Focus"},{"key":"1429_CR8","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1569-9056(14)60052-X","volume":"13","author":"BE Ayres","year":"2014","unstructured":"Ayres\u00a0BE, Hounsome\u00a0L, Alnajjar\u00a0H, Sharma\u00a0D, Verne\u00a0J, Watkin\u00a0NA (2014) 50 Has centralisation of penile cancer services in the United Kingdom improved survival? Eur Urol Suppl 13:e50","journal-title":"Eur Urol Suppl"},{"key":"1429_CR9","doi-asserted-by":"publisher","first-page":"e0195673","DOI":"10.1371\/journal.pone.0195673","volume":"13","author":"MJ Kilsdonk","year":"2018","unstructured":"Kilsdonk\u00a0MJ, Siesling\u00a0S, van Dijk\u00a0BAC, Wouters\u00a0MW, van Harten\u00a0WH (2018) What drives centralisation in cancer care? PLoS ONE 13:e195673","journal-title":"PLoS ONE"},{"key":"1429_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.urology.2015.12.058","volume":"90","author":"RS Matulewicz","year":"2016","unstructured":"Matulewicz\u00a0RS, Flum\u00a0AS, Helenowski\u00a0I, Jovanovic\u00a0B, Palis\u00a0B, Bilimoria\u00a0KY et\u00a0al (2016) Centralization of penile cancer management in the United States: a combined analysis of the American board of urology and national cancer data base. Urology 90:82\u201388","journal-title":"Urology"},{"key":"1429_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","volume":"159","author":"MA Rubin","year":"2001","unstructured":"Rubin\u00a0MA, Kleter\u00a0B, Zhou\u00a0M, Ayala\u00a0G, Cubilla\u00a0AL, Quint\u00a0WG et\u00a0al (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159:1211\u20131218","journal-title":"Am J Pathol"},{"key":"1429_CR12","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00345-018-2549-3","volume":"37","author":"L Cindolo","year":"2019","unstructured":"Cindolo\u00a0L, Spiess\u00a0PE, Bada\u00a0M, Chipollini\u00a0JJ, Nyirady\u00a0P, Chiodini\u00a0P et\u00a0al (2019) Adherence to EAU guidelines on penile cancer translates into better outcomes: a\u00a0multicenter international study. World J Urol 37:1649\u20131657","journal-title":"World J Urol"},{"key":"1429_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.euf.2019.01.013","volume":"5","author":"MH Kamel","year":"2019","unstructured":"Kamel\u00a0MH (2019) Should the care of penile cancer be confined to centralized centers of excellence? Eur Urol Focus 5:735\u2013736","journal-title":"Eur Urol Focus"},{"key":"1429_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bju.12993","volume":"117","author":"P Kirrander","year":"2016","unstructured":"Kirrander\u00a0P, Sherif\u00a0A, Friedrich\u00a0B, Lambe\u00a0M, Hakansson\u00a0U (2016) Steering committee of the Swedish national penile cancer R. Swedish national penile cancer register: incidence, tumour characteristics, management and survival. BJU Int 117:287\u2013292","journal-title":"BJU Int"},{"key":"1429_CR15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","volume":"96","author":"S Minhas","year":"2005","unstructured":"Minhas\u00a0S, Kayes\u00a0O, Hegarty\u00a0P, Kumar\u00a0P, Freeman\u00a0A, Ralph\u00a0D (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96:1040\u20131043","journal-title":"BJU Int"},{"key":"1429_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/107327480200900405","volume":"9","author":"MR Pow-Sang","year":"2002","unstructured":"Pow-Sang\u00a0MR, Benavente\u00a0V, Pow-Sang\u00a0JE, Morante\u00a0C, Meza\u00a0L, Baker\u00a0M et al (2002) Cancer of the penis. Cancer Control 9:305\u2013314","journal-title":"Cancer Control"},{"key":"1429_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/sm2.56","volume":"3","author":"K Scarberry","year":"2015","unstructured":"Scarberry\u00a0K, Angermeier\u00a0KW, Montague\u00a0D, Campbell\u00a0S, Wood\u00a0HM (2015) Outcomes for organ-preserving surgery for penile cancer. Sex Med 3:62\u201366","journal-title":"Sex Med"},{"key":"1429_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","volume":"54","author":"JA Leijte","year":"2008","unstructured":"Leijte\u00a0JA, Kirrander\u00a0P, Antonini\u00a0N, Windahl\u00a0T, Horenblas\u00a0S (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a\u00a0two-centre analysis of 700\u00a0patients. Eur Urol 54:161\u2013168","journal-title":"Eur Urol"},{"key":"1429_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","volume":"85","author":"R Veeratterapillay","year":"2015","unstructured":"Veeratterapillay\u00a0R, Teo\u00a0L, Asterling\u00a0S, Greene\u00a0D (2015) Oncologic outcomes of penile cancer treatment at a\u00a0UK supraregional center. Urology 85:1097\u20131103","journal-title":"Urology"},{"key":"1429_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","volume":"188","author":"P Philippou","year":"2012","unstructured":"Philippou\u00a0P, Shabbir\u00a0M, Malone\u00a0P, Nigam\u00a0R, Muneer\u00a0A, Ralph\u00a0DJ et al (2012) Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J\u00a0Urol 188:803\u2013808","journal-title":"J Urol"},{"key":"1429_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/bju.14222","volume":"122","author":"D Sri","year":"2018","unstructured":"Sri\u00a0D, Sujenthiran\u00a0A, Lam\u00a0W, Minter\u00a0J, Tinwell\u00a0BE, Corbishley\u00a0CM et al (2018) A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer. BJU Int 122:576\u2013582","journal-title":"BJU Int"},{"key":"1429_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urolonc.2017.07.025","volume":"36","author":"M Albersen","year":"2018","unstructured":"Albersen\u00a0M, Parnham\u00a0A, Joniau\u00a0S, Sahdev\u00a0V, Christodoulidou\u00a0M, Castiglione\u00a0F et\u00a0al (2018) Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma. Urol Oncol 36:141\u2013146","journal-title":"Urol Oncol"},{"key":"1429_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","volume":"192","author":"RS Djajadiningrat","year":"2014","unstructured":"Djajadiningrat\u00a0RS, van Werkhoven\u00a0E, Meinhardt\u00a0W, van Rhijn\u00a0BW, Bex\u00a0A, van der Poel\u00a0HG et al (2014) Penile sparing surgery for penile cancer-does it affect survival? J\u00a0Urol 192:120\u2013125","journal-title":"J Urol"},{"key":"1429_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00345-019-02793-9","volume":"38","author":"AK Lindner","year":"2020","unstructured":"Lindner\u00a0AK, Schachtner\u00a0G, Steiner\u00a0E, Kroiss\u00a0A, Uprimny\u00a0C, Steinkohl\u00a0F et al (2020) Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival. World J Urol 38:417\u2013424","journal-title":"World J Urol"},{"key":"1429_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00432-019-02864-9","volume":"145","author":"M Bada","year":"2019","unstructured":"Bada\u00a0M, Berardinelli\u00a0F, Nyirady\u00a0P, Varga\u00a0J, Ditonno\u00a0P, Battaglia\u00a0M et\u00a0al (2019) Adherence to the EAU guidelines on penile cancer treatment: European, multicentre, retrospective study. J\u00a0Cancer Res Clin Oncol 145:921\u2013926","journal-title":"J Cancer Res Clin Oncol"},{"key":"1429_CR26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1464-410X.2008.07744.x","volume":"102","author":"CM Naumann","year":"2008","unstructured":"Naumann\u00a0CM, Alkatout\u00a0I, Al-Najar\u00a0A, Korda\u00a0JB, Hegele\u00a0A, Bolenz\u00a0C et al (2008) Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis. BJU Int 102:1102\u20131106","journal-title":"BJU Int"},{"key":"1429_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.urology.2006.03.052","volume":"68","author":"E Hungerhuber","year":"2006","unstructured":"Hungerhuber\u00a0E, Schlenker\u00a0B, Karl\u00a0A, Frimberger\u00a0D, Rothenberger\u00a0KH, Stief\u00a0CG et al (2006) Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 68:621\u2013625","journal-title":"Urology"},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0022-5347(05)66337-9","volume":"165","author":"E Solsona","year":"2001","unstructured":"Solsona\u00a0E, Iborra\u00a0I, Rubio\u00a0J, Casanova\u00a0JL, Ricos\u00a0JV, Calabuig\u00a0C (2001) Prospective validation of the association of local tumor stage and grade as a\u00a0predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J\u00a0Urol 165:1506\u20131509","journal-title":"J Urol"},{"key":"1429_CR29","volume-title":"EAU guidelines on penile cancer","author":"EAU","year":"2020","unstructured":"EAU (2020) EAU guidelines on penile cancer"},{"key":"1429_CR30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00345-019-02866-9","volume":"38","author":"J Vanthoor","year":"2020","unstructured":"Vanthoor\u00a0J, Thomas\u00a0A, Tsaur\u00a0I, Albersen\u00a0M, European Reference Network for rare urogenital diseases and complex conditions (eUROGEN) (2020) Making surgery safer by centralization of care: impact of case load in penile cancer. World J Urol 38:1385\u20131390","journal-title":"World J Urol"},{"key":"1429_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","volume":"173","author":"BK Kroon","year":"2005","unstructured":"Kroon\u00a0BK, Horenblas\u00a0S, Lont\u00a0AP, Tanis\u00a0PJ, Gallee\u00a0MP, Nieweg\u00a0OE (2005) Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J\u00a0Urol 173:816\u2013819","journal-title":"J Urol"},{"issue":"159","key":"1429_CR32","first-page":"e7","volume":"36","author":"SL Woldu","year":"2018","unstructured":"Woldu\u00a0SL, Ci\u00a0B, Hutchinson\u00a0RC, Krabbe\u00a0LM, Singla\u00a0N, Passoni\u00a0NM et al (2018) Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: a propensity-score matched analysis. Urol Oncol 36(159):e7\u2013e17","journal-title":"Urol Oncol"},{"key":"1429_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1245\/s10434-018-7066-5","volume":"26","author":"Y Zhu","year":"2019","unstructured":"Zhu\u00a0Y, Gu\u00a0WJ, Xiao\u00a0WJ, Wang\u00a0BH, Azizi\u00a0M, Spiess\u00a0PE et\u00a0al (2019) Important therapeutic considerations in T1b penile cancer: prognostic significance and adherence to treatment guidelines. Ann Surg Oncol 26:685\u2013691","journal-title":"Ann Surg Oncol"},{"issue":"578","key":"1429_CR34","first-page":"e11","volume":"37","author":"FA Mistretta","year":"2019","unstructured":"Mistretta\u00a0FA, Mazzone\u00a0E, Palumbo\u00a0C, Knipper\u00a0S, Tian\u00a0Z, Nazzani\u00a0S et\u00a0al (2019) Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: effect on survival and complication rates. Urol Oncol 37(578):e11\u2013e19","journal-title":"Urol Oncol"},{"key":"1429_CR35","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1002\/cncr.25091","volume":"116","author":"TV Johnson","year":"2010","unstructured":"Johnson\u00a0TV, Hsiao\u00a0W, Delman\u00a0KA, Jani\u00a0AB, Brawley\u00a0OW, Master\u00a0VA (2010) Extensive inguinal lymphadenectomy improves overall 5\u2011year survival in penile cancer patients: results from the surveillance, epidemiology, and end results program. Cancer 116:2960\u20132966","journal-title":"Cancer"},{"issue":"471","key":"1429_CR36","first-page":"e19","volume":"36","author":"N Soodana-Prakash","year":"2018","unstructured":"Soodana-Prakash\u00a0N, Koru-Sengul\u00a0T, Miao\u00a0F, Lopategui\u00a0DM, Savio\u00a0LF, Moore\u00a0KJ et al (2018) Lymph node yield as a\u00a0predictor of overall survival following inguinal lymphadenectomy for penile cancer. Urol Oncol 36(471):e19\u2013e27","journal-title":"Urol Oncol"},{"key":"1429_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1590\/S1677-5538.IBJU.2014.0304","volume":"41","author":"I Tsaur","year":"2015","unstructured":"Tsaur\u00a0I, Biegel\u00a0C, Gust\u00a0K, Huesch\u00a0T, Borgmann\u00a0H, Brandt\u00a0MP et\u00a0al (2015) Feasibility, complications and oncologic results of a\u00a0limited inguinal lymph node dissection in the management of penile cancer. Int Braz J Urol 41:486\u2013495","journal-title":"Int Braz J Urol"},{"key":"1429_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.02.005","author":"R Suarez-Ibarrola","year":"2020","unstructured":"Suarez-Ibarrola\u00a0R, Zengerling\u00a0F, Haccius\u00a0M, Lebentrau\u00a0S, Schmid\u00a0HP, Bier\u00a0M et al (2020) Adherence to European association of urology and national comprehensive cancer network guidelines criteria for inguinal and pelvic lymph node dissection in penile cancer patients\u2014a survey assessment in German-speaking countries on behalf of the European prospective penile cancer study group. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2020.02.005","journal-title":"Eur Urol Focus"},{"issue":"8","key":"1429_CR39","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/jcm9082501","volume":"9","author":"R Nabavizadeh","year":"2020","unstructured":"Nabavizadeh\u00a0R, Petrinec\u00a0B, Necchi\u00a0A, Tsaur\u00a0I, Albersen\u00a0M, Master\u00a0V (2020) Utility of minimally invasive technology for inguinal lymph node dissection in penile cancer. J\u00a0Clin Med 9(8):2501","journal-title":"J Clin Med"},{"key":"1429_CR40","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s11255-016-1405-x","volume":"48","author":"ZJ Zou","year":"2016","unstructured":"Zou\u00a0ZJ, Liu\u00a0ZH, Tang\u00a0LY, Wang\u00a0YJ, Liang\u00a0JY, Zhang\u00a0RC et al (2016) Radiocolloid-based dynamic sentinel lymph node biopsy in penile cancer with clinically negative inguinal lymph node: an updated systematic review and meta-analysis. Int Urol Nephrol 48:2001\u20132013","journal-title":"Int Urol Nephrol"},{"key":"1429_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","volume":"65","author":"AM Hussein","year":"1990","unstructured":"Hussein\u00a0AM, Benedetto\u00a0P, Sridhar\u00a0KS (1990) Chemotherapy with cisplatin and 5\u2011fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65:433\u2013438","journal-title":"Cancer"},{"key":"1429_CR42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0022-5347(17)37327-5","volume":"147","author":"FV Shammas","year":"1992","unstructured":"Shammas\u00a0FV, Ous\u00a0S, Fossa\u00a0SD (1992) Cisplatin and 5\u2011fluorouracil in advanced cancer of the penis. J\u00a0Urol 147:630\u2013632","journal-title":"J Urol"},{"key":"1429_CR43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-121223","author":"M Roiner","year":"2017","unstructured":"Roiner\u00a0M, Maurer\u00a0O, Lebentrau\u00a0S, Gilfrich\u00a0C, Schafer\u00a0C, Haberl\u00a0C et\u00a0al (2017) Management of penile cancer patients: new aspects of a\u00a0rare tumour entity. Aktuelle Urol. https:\/\/doi.org\/10.1055\/s-0043-121223","journal-title":"Aktuelle Urol"},{"key":"1429_CR44","doi-asserted-by":"publisher","first-page":"32212","DOI":"10.18632\/oncotarget.4802","volume":"6","author":"S Zhang","year":"2015","unstructured":"Zhang\u00a0S, Zhu\u00a0Y, Ye\u00a0D (2015) Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy. Oncotarget 6:32212\u201332219","journal-title":"Oncotarget"},{"key":"1429_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","volume":"55","author":"G Pizzocaro","year":"2009","unstructured":"Pizzocaro\u00a0G, Nicolai\u00a0N, Milani\u00a0A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55:546\u2013551","journal-title":"Eur Urol"},{"key":"1429_CR46","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","volume":"14","author":"N Nicolai","year":"2016","unstructured":"Nicolai\u00a0N, Sangalli\u00a0LM, Necchi\u00a0A, Giannatempo\u00a0P, Paganoni\u00a0AM, Colecchia\u00a0M et al (2016) A combination of cisplatin and 5\u2011fluorouracil with a\u00a0taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings. Clin Genitourin Cancer 14:323\u2013330","journal-title":"Clin Genitourin Cancer"},{"key":"1429_CR47","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro\u00a0LC, Williams\u00a0DL, Daliani\u00a0D, Williams\u00a0MB, Osai\u00a0W, Kincaid\u00a0M et\u00a0al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a\u00a0phase II study. J\u00a0Clin Oncol 28:3851\u20133857","journal-title":"J Clin Oncol"},{"key":"1429_CR48","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/jco.2013.31.6_suppl.340","volume":"31","author":"A O\u2019Reilly","year":"2013","unstructured":"O\u2019Reilly\u00a0A, O\u2019Keeffe\u00a0M, Aherne\u00a0P, Mayer\u00a0NJ, Sweeney\u00a0JP, Power\u00a0DG (2013) Treatment of metastatic penile cancer in the adjuvant setting with ifosfamide, paclitaxel, and cisplatin: a single institution experience. J\u00a0Clin Oncol 31:340","journal-title":"J Clin Oncol"},{"key":"1429_CR49","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","volume":"85","author":"J Wang","year":"2015","unstructured":"Wang\u00a0J, Pettaway\u00a0CA, Pagliaro\u00a0LC (2015) Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes. Urology 85:1104\u20131110","journal-title":"Urology"},{"key":"1429_CR50","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.clon.2019.10.001","volume":"32","author":"FA Mistretta","year":"2020","unstructured":"Mistretta\u00a0FA, Cyr\u00a0SJ, Palumbo\u00a0C, Mazzone\u00a0E, Knipper\u00a0S, Tian\u00a0Z et al (2020) Adherence to guideline recommendations for perioperative chemotherapy in patients with pN2\u20113 M0 squamous cell carcinoma of the penis: temporal trends and survival outcomes. Clin Oncol (R Coll Radiol) 32:e93\u2013e101","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1429_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2020.1829039.1-8","author":"E Ulvskog","year":"2020","unstructured":"Ulvskog\u00a0E, Drevin\u00a0L, Persson\u00a0EK, Lambe\u00a0M, Kirrander\u00a0P, Ahlgren\u00a0J (2020) Oncological therapy to Swedish men with metastatic penile cancer 2000\u20132015. Acta Oncol. https:\/\/doi.org\/10.1080\/0284186X.2020.1829039.1-8","journal-title":"Acta Oncol"},{"key":"1429_CR52","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s00345-019-03052-7","volume":"38","author":"FA Distler","year":"2020","unstructured":"Distler\u00a0FA, Pahernik\u00a0S, Gakis\u00a0G, Hutterer\u00a0G, Lebentrau\u00a0S, Rink\u00a0M et al (2020) Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E\u2011PROPS study group survey. World J Urol 38:2523\u20132530","journal-title":"World J Urol"},{"key":"1429_CR53","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00120-009-2108-z","volume":"48","author":"C Protzel","year":"2009","unstructured":"Protzel\u00a0C, Ruppin\u00a0S, Milerski\u00a0S, Klebingat\u00a0KJ, Hakenberg\u00a0OW (2009) The current state of the art of chemotherapy of penile cancer: results of a\u00a0nationwide survey of German clinics. Urologe\u00a0A 48:1495\u20131498","journal-title":"Urologe A"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-020-01429-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-020-01429-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T06:57:25Z","timestamp":1613717845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-020-01429-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1007\/s00120-020-01429-w","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"17 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I.\u00a0Tsaur weist auf folgende Beziehungen hin: Advisory Board: Sanofi, MSD, Pfizer; Referentent\u00e4tigkeit: Sanofi, Astellas, Janssen; Unterst\u00fctzung bei Kongressreisen: Astellas, Janssen, Ipsen, Pfizer. F\u00fcr A.\u00a0Thomas, F.\u00a0K\u00f6lling und A.\u00a0Haferkamp bestehen keine Interessenkonflikte.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}